Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,166,814 papers from all fields of science
Search
Sign In
Create Free Account
Debio 1347
Known as:
Debiopharm 1347
, FGFR Inhibitor Debio 1347
, debio 1347-101
An orally bioavailable inhibitor of the fibroblast growth factor receptor subtypes 1 (FGFR-1), 2 (FGFR-2) and 3 (FGFR-3), with potential…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
CH5183284
NCIt Antineoplastic Agent Terminology
Receptor Tyrosine Kinase Inhibition
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate
M. Bobardt
,
Joseph Kuo
,
+5 authors
P. Gallay
PLoS ONE
2019
Corpus ID: 64293680
Antiretroviral therapy (ART) suppresses HIV replication, but does not cure the infection because replication-competent virus…
Expand
2019
2019
AB065. P-36. Debio 1347 in patients with cholangiocarcinoma harboring an FGFR gene alteration: preliminary results
M. Ng
,
L. Goyal
,
+15 authors
K. Flaherty
Hepatobiliary surgery and nutrition
2019
Corpus ID: 91970300
Background Cholangiocarcinoma (CCA), an aggressive epithelial neoplasm of biliary tract, presents limited treatment options and…
Expand
2018
2018
Safety and efficacy of the selective FGFR inhibitor debio 1347 in phase I study patients with FGFR genomically activated advanced biliary tract cancer (BTC).
J. Cleary
,
M. Voss
,
+12 authors
J. Baselga
2018
Corpus ID: 79550365
447Background: BTC are aggressive tumors with limited treatment options and poor overall survival. Aberrant FGFR signaling has…
Expand
2018
2018
Epidemiology of tuberculosis in Spain. Results obtained by the National Epidemiological Surveillance Network in 2015.
Rosa Cano-Portero
,
Rocío Amillategui-Dos Santos
,
Raquel Boix-Martínez
,
Amparo Larrauri-Cámara
Enfermedades Infecciosas y Microbiologia Clinica
2018
Corpus ID: 196495121
2017
2017
Debio 1347, an oral FGFR inhibitor: Results from a first-in-human, phase I dose-escalation study in patients with FGFR genomically activated advanced solid tumors.
M. Voss
,
C. Hierro
,
+14 authors
J. Baselga
2017
Corpus ID: 79549332
2500Background: Oncogenic alterations in fibroblast growth factor receptors (FGFR) are seen across multiple solid tumor…
Expand
2015
2015
Preliminary clinical pharmacokinetics and pharmacodynamics of Debio 1347 (CH5183284), a novel FGFR inhibitor.
C. Zanna
,
A. Vaslin
,
+10 authors
V. Nicolas-Metral
2015
Corpus ID: 80053847
2540 Background: Deregulated fibroblast growth factor receptor (FGFR) signaling is associated with tumorigenesis. Debio 1347 is…
Expand
2011
2011
Oclusión intencional de la arteria subclavia izquierda durante el tratamiento endovascular de la aorta torácica descendente
H. Bertoni
,
Fabián A. Azzari
,
+6 authors
J. Leguizamón
2011
Corpus ID: 58247255
Resumen es: Introduccion La seguridad y la eficacia del tratamiento endovascular de la aorta toracica descendente dependen de…
Expand
2009
2009
Fenologia de Algumas Espécies do Gênero Cyclocephala (Coleoptera, Scarabaeidae) do Leste e Centro-Oeste do Paraná, Brasil
P. Riehs
2009
Corpus ID: 162566629
Sao analisados resultados de capturas de seis especies do genero Cyclocephala (Coleoptera, Scarabaeidae) fototacticos feitas com…
Expand
2008
2008
Tratamiento laparoscópico de la litiasis de la vía biliar principal asociada a litiasis vesicular
Alexandra Catalina Mandry
,
M. Bun
,
María Laura Aued
,
Mario L. Iovaldi
,
P. Capitanich
2008
Corpus ID: 71218542
Review
1994
Review
1994
Intraspecific structure of the northern right whale dolphin (Lissodelphis borealis): The power of an analysis of molecular variation for differentiating genetic stocks
Andrew E. Iiizon
,
C. Leduc
,
R. LeDuc
1994
Corpus ID: 53658753
The northern right whale dolphin (Lissodelphis borealis) has experienced very high levels of fishery-induced mortality in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE